STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
Not Applicable
Completed
- Conditions
- Celiac Disease
- Interventions
- Behavioral: Educational Text Message Reminders
- First Posted Date
- 2015-06-01
- Last Posted Date
- 2016-05-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 61
- Registration Number
- NCT02458898
- Locations
- 🇺🇸
Stanford University Pediatric Gastroenterology Department, Palo Alto, California, United States
Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF
Not Applicable
Recruiting
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: Conventional AF Ablation with PVIProcedure: FIRM-guided ablation plus PVI
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 120
- Registration Number
- NCT02456233
- Locations
- 🇺🇸
Veterans Affairs Medical Center, San Diego, California, United States
🇺🇸Stanford University, Stanford, California, United States
Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness
Not Applicable
Completed
- Conditions
- Juvenile Idiopathic ArthritisDepressionInflammatory Bowel DiseaseSystemic Lupus ErythematosusAnxiety
- Interventions
- Behavioral: Web-based Cognitive Behavioral Therapy
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2016-04-26
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 14
- Registration Number
- NCT02453880
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
Not Applicable
Withdrawn
- Conditions
- Hematopoietic Stem Cell TransplantBone Marrow Transplant
- Interventions
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2017-07-28
- Lead Sponsor
- Stanford University
- Registration Number
- NCT02451462
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms
Terminated
- Conditions
- DepressionAnxiety
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 25
- Registration Number
- NCT02449499
- Locations
- 🇺🇸
Stanford Psychiatry and Behavioral Science, Palo Alto, California, United States
Strength Training Regimen for Normal Weight Diabetics
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Behavioral: Exercise Intervention
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 289
- Registration Number
- NCT02448498
- Locations
- 🇺🇸
Stanford, Palo Alto, California, United States
Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial
Phase 3
Completed
- Conditions
- Pregnancy, Unwanted
- Interventions
- Drug: standard lidocaine paracervical blockDrug: vaginal 2% Xylocaine
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 142
- Registration Number
- NCT02447029
- Locations
- 🇺🇸
Planned Parenthood Mar Monte, San Jose, California, United States
Transcutaneous Bilirubinometry in Neonates With the Bilicare System
Completed
- Conditions
- Transcutaneous Bilirubinometry
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 113
- Registration Number
- NCT02445755
Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: Herbal treatment (SA100)
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 15
- Registration Number
- NCT02442960
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Carcinoma
- Interventions
- Drug: 68Ga-DOTA-BombesinProcedure: Magnetic Resonance Imaging (MRI) scanProcedure: Positron Emission Tomography (PET) scan
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 10
- Registration Number
- NCT02440308
- Locations
- 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath